Chevy Chase Trust’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Chevy Chase Trust's NVAX Position: Q2 2022 in Review
Chevy Chase Trust sold out of Novavax (NVAX) in Q2 2022, closing a stake of 5,005 shares — an estimated $368K sold.
Chevy Chase Trust first reported a position in NVAX in Q4 2013 and held it in 27 quarters. The position peaked at $1.08M in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.
- Chevy Chase Trust reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
- Chevy Chase Trust sold 5,005 Novavax shares in Q2 2022, an estimated $368K.
- Chevy Chase Trust first reported a position in Novavax in Q4 2013 and held it in 27 quarters.
- Chevy Chase Trust's Novavax position peaked at $1.08M in Q2 2021.
- 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.
Based on Chevy Chase Trust's 13F filing for Q2 2022, filed 10 Aug 2022.